123 related articles for article (PubMed ID: 6127885)
21. Prenalterol in symptomatic sinus node dysfunction.
Feleke E; Rydén L; Smedgård P; Westerling S
Am Heart J; 1985 Jan; 109(1):185-7. PubMed ID: 2857060
[No Abstract] [Full Text] [Related]
22. Dose-response relationship in normal subjects of prenalterol, a beta-adrenergic agonist with positive inotropic and resistance lowering effects.
Rasmussen S; Høilund-Carlsen PF; Hesse B; Hartling OJ; Fabricius J; Dige-Petersen H; Giese J
Eur J Clin Pharmacol; 1984; 27(5):539-43. PubMed ID: 6151507
[TBL] [Abstract][Full Text] [Related]
23. Effects of i.v. prenalterol in patients with severe cardiac failure at rest and during exercise.
Doering W; Wauer B; Isbary J
Acta Med Scand Suppl; 1982; 659():307-14. PubMed ID: 6127897
[TBL] [Abstract][Full Text] [Related]
24. [Prenalterol (CGP 7760 B), a new cardioselective beta 1-adrenoceptor-agonist (author's transl)].
Piepenbrock S; Reichelt W; Zenz M; Seitz W; Sikalieh E
Anaesthesist; 1981 Mar; 30(3):118-23. PubMed ID: 6111933
[TBL] [Abstract][Full Text] [Related]
25. A comparison of the hemodynamic effects of prenalterol and isoprenaline in patients with complete heart block.
Svendsen TL; Pelle H; Lønholt C; Bonde J; Kampmann JP; Lindeneg O
J Cardiovasc Pharmacol; 1984; 6(4):693-6. PubMed ID: 6206327
[TBL] [Abstract][Full Text] [Related]
26. Central and peripheral haemodynamic effects of prenalterol in patients with coronary heart disease.
Svendsen TL; Carlsen JE; Hartling OJ; Trap-Jensen J
Clin Physiol; 1981 Oct; 1(5):461-9. PubMed ID: 7199993
[TBL] [Abstract][Full Text] [Related]
27. Acute haemodynamic effects of oral prenalterol in severe heart failure.
Petch MC; Wisbey C; Ormerod O; Scott C; Goodfellow RM
Br Heart J; 1984 Jul; 52(1):49-52. PubMed ID: 6146324
[TBL] [Abstract][Full Text] [Related]
28. Effects of prenalterol administered orally in patients with congestive heart failure.
Hjalmarson A; Abelardo N; Caidahl K; Reyes C; Waagstein F; Wallentin I; Wikstrand J; Estrada-Yamamoto M
Acta Med Scand Suppl; 1982; 659():201-20. PubMed ID: 6127890
[TBL] [Abstract][Full Text] [Related]
29. Effect of prenalterol in asthmatic patients.
Löfdahl CG; Svedmyr N
Eur J Clin Pharmacol; 1982 Oct; 23(4):297-302. PubMed ID: 6129142
[TBL] [Abstract][Full Text] [Related]
30. Basic pharmacological properties of prenalterol.
Mattsson H; Hedberg A; Carlsson E
Acta Med Scand Suppl; 1982; 659():9-37. PubMed ID: 6127902
[No Abstract] [Full Text] [Related]
31. Cardioselectivity of prenalterol and isoproterenol.
Jennings G; Bobik A; Oddie C; Hargreaves M; Korner P
Clin Pharmacol Ther; 1983 Dec; 34(6):749-57. PubMed ID: 6641090
[TBL] [Abstract][Full Text] [Related]
32. Prenalterol in cardiogenic shock following acute myocardial infarction.
Coma-Canella I; Lopez-Sendon J; Jadraque LM
Am Heart J; 1984 Jun; 107(6):1195-201. PubMed ID: 6144265
[TBL] [Abstract][Full Text] [Related]
33. Dose-dependent haemodynamic response to prenalterol in patients with congestive heart failure.
Leinberger H; Mäurer W; Haueisen H; Schuler G; Kübler W
Acta Med Scand Suppl; 1982; 659():299-306. PubMed ID: 6127896
[TBL] [Abstract][Full Text] [Related]
34. The clinical use of inotropes in cardiac failure: dopamine, dobutamine, prenalterol and pirbuterol.
Rae AP; Tweddel AC; Hutton I
Herz; 1983 Feb; 8(1):23-33. PubMed ID: 6832690
[TBL] [Abstract][Full Text] [Related]
35. [Echocardiographic measurements of hemodynamic effects and pharmacokinetics of prenalterol (author's transl)].
Oltmanns D; Wester HA; Stein R
Z Kardiol; 1981 May; 70(5):394-8. PubMed ID: 6115520
[TBL] [Abstract][Full Text] [Related]
36. Haemodynamic effects of prenaterol and cardiac glycosides in patients with recent myocardial infarction.
Boström PA; Andersson J; Johansson BW; Lilja B; Thorell J; Tidfält K; Westerling S
Eur J Clin Invest; 1984 Jun; 14(3):175-80. PubMed ID: 6147253
[TBL] [Abstract][Full Text] [Related]
37. Pharmacokinetics of prenalterol in healthy subjects and patients with congestive heart failure.
Rönn O
Acta Med Scand Suppl; 1982; 659():89-98. PubMed ID: 6127901
[TBL] [Abstract][Full Text] [Related]
38. Short and long-term effects of hydralazine and combined hydralazine and prenalterol therapy in patients with congestive heart failure.
Drexler H; Löllgen H; Just H
Acta Med Scand Suppl; 1982; 659():315-24. PubMed ID: 6127898
[No Abstract] [Full Text] [Related]
39. Cardio-selective beta adrenergic stimulation with prenalterol in the conscious dog.
Manders WT; Vatner SF; Braunwald E
J Pharmacol Exp Ther; 1980 Oct; 215(1):266-70. PubMed ID: 6109017
[TBL] [Abstract][Full Text] [Related]
40. The immediate haemodynamic and electrophysiological response to prenalterol during fixed rate pacing in patients with chronic ischaemic heart disease.
Sire S; Amlie JP; Simonsen S
Acta Pharmacol Toxicol (Copenh); 1986 Jan; 58(1):43-8. PubMed ID: 3953293
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
